GlassScriptPhysician profile
Niteesh Bharara
NPI 1144480989
$25,152.05
in general payments reported to CMS, 2019-2025
41 companies · $3,112 in 2025
The $3,112 reported for 2025 was more than what 86% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $2,377 · 2021: $1,246 · 2022: $1,275 · 2023: $1,443 · 2024: $554 · 2025: $3,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,450 · Travel and Lodging: $1,525 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,449.55 |
| Travel and Lodging | $1,525.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $133.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $14,855.06 | 2019-2020 | |
| Medtronic, INC. | $3,057.38 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $2,554.58 | 2019-2025 | Proclaim, Eterna |
| Abbvie INC. | $759.35 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Mml US, INC. | $697.31 | 2023-2025 | Reactiv8 |
| Nevro Corp. | $665.70 | 2019-2024 | Senza |
| Medtronic USA, INC. | $311.59 | 2019-2020 | |
| Stimwave Technologies Incorporated | $296.42 | 2019 | |
| Aesculap Implant Systems, LLC | $190.48 | 2021-2022 | |
| Boston Scientific Corporation | $166.19 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| 4web, INC. | $143.51 | 2020 | |
| Averitas Pharma INC. | $128.42 | 2023 | Qutenza |
| Bioventus LLC | $122.48 | 2023 | Stimrouter Implantable Kit |
| Grt US Holding, INC. | $116.66 | 2021 | |
| Vertiflex, INC. | $111.11 | 2019 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niteesh Bharara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.